Roche partner Zealand posts Phase 2 data for amylin obesity drug
Roche partner Zealand posts Phase 2 data for amylin obesity drug
Body unavailable. Use the original source.
Roche partner Zealand posts Phase 2 data for amylin obesity drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.